Cropley I - Search Results

1

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, Rappuoli R, Dougan G. Douce G, et al. Among authors: cropley i. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1644-8. doi: 10.1073/pnas.92.5.1644. Proc Natl Acad Sci U S A. 1995. PMID: 7878032 Free PMC article.

2

A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.

Roberts M, Bacon A, Rappuoli R, Pizza M, Cropley I, Douce G, Dougan G, Marinaro M, McGhee J, Chatfield S. Roberts M, et al. Among authors: cropley i. Infect Immun. 1995 Jun;63(6):2100-8. doi: 10.1128/iai.63.6.2100-2108.1995. Infect Immun. 1995. PMID: 7768587 Free PMC article.

3

Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.

Cropley I, Douce G, Roberts M, Chatfield S, Pizza M, Marsili I, Rappuoli R, Dougan G. Cropley I, et al. Vaccine. 1995 Dec;13(17):1643-8. doi: 10.1016/0264-410x(95)00134-m. Vaccine. 1995. PMID: 8719514

4

The development of oral vaccines based on live attenuated Salmonella strains.

Chatfield S, Roberts M, Londono P, Cropley I, Douce G, Dougan G. Chatfield S, et al. Among authors: cropley i. FEMS Immunol Med Microbiol. 1993 Jun;7(1):1-7. doi: 10.1111/j.1574-695X.1993.tb00374.x. FEMS Immunol Med Microbiol. 1993. PMID: 8364518 Review.

5

Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.

Roberts M, Cropley I, Chatfield S, Dougan G. Roberts M, et al. Among authors: cropley i. Vaccine. 1993;11(8):866-72. doi: 10.1016/0264-410x(93)90363-3. Vaccine. 1993. PMID: 8356847

6

Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.

Capocci SJ, Sewell J, Smith C, Cropley I, Bhagani S, Solamalai A, Morris S, Abubakar I, Johnson MA, Lipman MCI. Capocci SJ, et al. Among authors: cropley i. J Infect. 2020 Aug;81(2):289-296. doi: 10.1016/j.jinf.2020.05.055. Epub 2020 May 27. J Infect. 2020. PMID: 32473234

7

Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis.

Sewell J, Capocci S, Johnson J, Solamalai A, Hopkins S, Cropley I, Webster DP, Lipman M. Sewell J, et al. Among authors: cropley i. J Infect. 2015 Apr;70(4):317-23. doi: 10.1016/j.jinf.2014.10.014. Epub 2014 Nov 5. J Infect. 2015. PMID: 25452045

8

Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis.

Whitehead TC, Lovering AM, Cropley IM, Wade P, Davidson RN. Whitehead TC, et al. Among authors: cropley im. Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):794-7. doi: 10.1007/s100960050189. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9923523

9

Improved treatment completion for tuberculosis patients: The case for a dedicated social care team.

Izzard A, Wilders S, Smith C, Wickers M, Hart T, Dos Santos J, Booth H, Creer D, Cropley I, Lozewicz S, White J, Lipman M. Izzard A, et al. Among authors: cropley i. J Infect. 2021 Mar;82(3):e1-e3. doi: 10.1016/j.jinf.2020.12.019. Epub 2020 Dec 24. J Infect. 2021. PMID: 33359406

10

Citrobacter koseri meningitis: another freediving risk?

Pollara G, Savy L, Cropley I, Hopkins S. Pollara G, et al. Among authors: cropley i. J Infect. 2011 Jan;62(1):101-3. doi: 10.1016/j.jinf.2010.09.036. Epub 2010 Oct 7. J Infect. 2011. PMID: 20933000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters